Alimentary Pharmacology & Therapeutics · 2009 · 95 citations · 24 references
MedicineDiagnostic SciencesEarly DetectionGastroenterologyMolecular DiagnosticsBiomarker ModelingFunctional Gastrointestinal DisordersIrritable Bowel SyndromeDiagnostic StrategyDiagnostic Strategy DevelopmentFunctional Gastrointestinal Disorder AssessmentFunctional Gastrointestinal SymptomsGastrointestinal Disease BiomarkersPositive Predictive ValuePredictive PerformanceSerum Biomarkers
BACKGROUND: Currently, no single serum biomarker can reliably differentiate irritable bowel syndrome (IBS) from other functional gastrointestinal disorders or organic diseases of the gastrointestinal tract. AIM: To develop and validate a diagnostic test using serum biomarkers to detect IBS. METHODS: Ten serum biomarkers were selected from a potential panel of 140 for their ability to differentiate IBS from non-IBS disease in blood samples from patients with IBS, other gastrointestinal disorders and healthy volunteers. A predictive modelling tool was developed to assess patterns and relationships among the 10 serum biomarkers that best differentiated IBS patients from healthy controls and patients with non-IBS gastrointestinal disease. This model was tested in a different cohort of patients and healthy controls (n = 516) to determine the predictive accuracy of differentiating IBS from non-IBS. RESULTS: The sensitivity and specificity of the 10-biomarker algorithm for differentiating IBS from non-IBS was 50% and 88% respectively. The positive predictive value was 81%, and the negative predictive value was 64% at 50% IBS prevalence in the validation cohort. Overall accuracy was 70%. CONCLUSIONS: Assessing serum biomarker patterns can differentiate IBS from non-IBS with reasonable sensitivity and specificity. Assessing serum biomarkers in an overall diagnostic strategy may allow earlier diagnosis and treatment for patients with IBS.
24
Leo Breiman · Machine Learning · 2001 · 126.2K citations · Full text
Harrison's principles of internal medicine
Choice Reviews Online · 2008 · 3.1K citations
Bacterial flagellin is a dominant antigen in Crohn disease
Michael J. Lodes, Yingzi Cong, Charles O. Elson et al. · Journal of Clinical Investigation · 2004 · 712 citations · Full text
Bacterial flagellin is a dominant antigen in Crohn disease
Michael J. Lodes, Yingzi Cong, Charles O. Elson et al. · Journal of Clinical Investigation · 2004 · 688 citations · Full text
David S. Sanders, Martyn J. Carter, David P. Hurlstone et al. · The Lancet · 2001 · 392 citations